Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Appelbaum · SciRah

Researcher profile · Semantic Scholar

F. Appelbaum

Share profile

F. Appelbaum — researcher profile on SciRah

h-index: 125
Works: 844
Citations: 67K

Most-cited papers

Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel.
H. Döhner, A. Wei, F. Appelbaum, C. Craddock +19 more
2022Blood2,547 citations Open access
Semantic Scholar
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
W. Stock, S. Luger, A. Advani, Jun Yin +24 more
2019Blood456 citations Open access
Semantic Scholar
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
M. Tallman, Eunice S. Wang, J. Altman, F. Appelbaum +30 more
2019The Journal of the National Comprehensive Cancer Network371 citations Open access
Semantic Scholar
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
D. Pollyea, D. Bixby, A. Perl, V. Bhatt +30 more
2021The Journal of the National Comprehensive Cancer Network273 citations
Semantic Scholar
Impact of NPM1/FLT3-ITD genotypes defined by the2017 European LeukemiaNet in patients with acute myeloid leukemia.
K. Döhner, C. Thiede, N. Jahn, E. Panina +33 more
2019Blood181 citations Open access
Semantic Scholar
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
R. Nakamura, W. Saber, Michael J. Martens, Alyssa Ramirez +18 more
2021Journal of Clinical Oncology117 citations Open access
Semantic Scholar
Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma
D. Green, M. Pont, Blythe Sather, A. Cowan +15 more
2018Blood113 citations
Semantic Scholar
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study
Celalettin Ustun, J. Le-Rademacher, Hai-Lin Wang, M. Othus +28 more
2019Leukemia92 citations Open access
Semantic Scholar
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
R. Larson, S. Mandrekar, L. Huebner, B. Sanford +28 more
2021Leukemia89 citations Open access
Semantic Scholar
Effectiveness of addition of sirolimus to cyclosporine and mycophenolate mofetil-based graft-versus-host disease prophylaxis after unrelated nonmyeloablative hematopoietic cell transplantation: A multicentre phase III randomized trial
B. Sandmaier, B. Kornblit, B. Storer, G. Olesen +14 more
2019The Lancet Haematology88 citations Open access
Semantic Scholar
Conditioning Intensity and Peri-Transplant Flow Cytometric MRD Dynamics in Adult AML.
Gabrielle Paras, L. Morsink, M. Othus, F. Milano +11 more
2022Blood81 citations Open access
Semantic Scholar
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy.
Bhagirathbhai R. Dholaria, B. Savani, B. Hamilton, B. Oran +25 more
2020Biology of Blood and Marrow Transplantation73 citations Open access
Semantic Scholar
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
Frank G. Rücker, Ling Du, T. J. Luck, A. Benner +26 more
2021Leukemia68 citations Open access
Semantic Scholar
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis
Sara Zarnegar-Lumley, T. Alonzo, R. Gerbing, M. Othus +24 more
2023Blood Advances65 citations Open access
Semantic Scholar
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535).
J. Lancet, A. Moseley, S. Coutre, D. DeAngelo +6 more
2020Blood Advances65 citations Open access
Semantic Scholar
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
A. Advani, E. Larsen, K. Laumann, S. Luger +19 more
2021Blood Advances55 citations Open access
Semantic Scholar
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial.
M. Voso, R. Larson, Dan A. Jones, G. Marcucci +33 more
2020Blood Advances55 citations Open access
Semantic Scholar
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials
M. Pasquini, B. Logan, Richard J. Jones, A. Alousi +17 more
2018Biology of Blood and Marrow Transplantation53 citations Open access
Semantic Scholar
Phase 1/2 Trial of GCLAM with Dose-Escalated Mitoxantrone for Newly Diagnosed AML or Other High-Grade Myeloid Neoplasms
A. Halpern, M. Othus, Emily M. Huebner, B. Scott +12 more
2018Leukemia47 citations Open access
Semantic Scholar
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: Analysis from CALGB 10403 and the CIBMTR
M. Wieduwilt, W. Stock, A. Advani, S. Luger +23 more
2021Leukemia41 citations Open access
Semantic Scholar
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
N. Jahn, E. Jahn, Maral Saadati, L. Bullinger +20 more
2022Leukemia39 citations Open access
Semantic Scholar
Multi-Site 11-Year Experience of Less-Intensive versus Intensive Therapies in Acute Myeloid Leukemia.
M. Sorror, B. Storer, A. Fathi, A. Brunner +27 more
2021Blood36 citations Open access
Semantic Scholar
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
E. Pogosova-Agadjanyan, A. Moseley, M. Othus, F. Appelbaum +18 more
2020Biomarker Research34 citations Open access
Semantic Scholar
NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Acute Myeloid Leukemia, Version 3.2019
M. Tallman, Eunice S. Wang, J. Altman, F. Appelbaum +31 more
201933 citations
Semantic Scholar
Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia (AML)
A. Advani, Hongli Li, L. Michaelis, B. C. Medeiros +6 more
2018Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis32 citations Open access
Semantic Scholar
Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome.
Frances Linzee Mabrey, K. Gardner, Kathleen K. Shannon Dorcy, Andrea M. Perdue +13 more
2020Blood Advances31 citations Open access
Semantic Scholar
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
C. Orvain, Jacob A. Wilson, M. Fang, B. Sandmaier +5 more
2022Haematologica25 citations Open access
Semantic Scholar
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia
P. Vo, T. Gooley, J. Rajendran, D. Fisher +10 more
2019Haematologica25 citations Open access
Semantic Scholar
Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia
Xue-Yan Chen, M. Othus, B. Wood, R. Walter +5 more
2020Leukemia and Lymphoma23 citations
Semantic Scholar
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).
J. Byrd, A. Ruppert, N. Heerema, Alese E. Halvorson +13 more
2018Blood Advances22 citations Open access
Semantic Scholar
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm AML patients.
M. Sorror, T. Gooley, B. Storer, A. Gerds +21 more
2022Blood20 citations Open access
Semantic Scholar
Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
E. Rodríguez-Arbolí, M. Othus, C. Orvain, Lucas C Zarling +8 more
2022Haematologica19 citations Open access
Semantic Scholar
Evidence generation and reproducibility in cell and gene therapy research: A call to action
Mohamed Abouelenein, A. Angelis, F. Appelbaum, N. Andrews +31 more
2021Molecular Therapy: Methods & Clinical Development19 citations Open access
Semantic Scholar
Wintrobe's clinical hematology: Fourteenth edition
J. Greer, D. Arber, B. Glader, A. List +5 more
201819 citations
Semantic Scholar
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
Lori S. Muffly, Jun Yin, S. Jacobson, Anna K. M. Wall +11 more
2022Blood Advances18 citations Open access
Semantic Scholar
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
I. Aldoss, Jun Yin, Anna K. M. Wall, K. Mrózek +12 more
2022Blood Advances18 citations Open access
Semantic Scholar
Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia
Alexander P. Hoffmann, Ashley L Besch, M. Othus, L. Morsink +5 more
2019Bone Marrow Transplantation18 citations Open access
Semantic Scholar
Utility of Treatment-Related Mortality (TRM) Score to Predict Outcomes of Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Lucas C Zarling, M. Othus, B. Sandmaier, F. Milano +7 more
2022Leukemia17 citations Open access
Semantic Scholar
Relationship Between Pre-Transplant Nutritional Status and Outcomes of Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
C. Orvain, Mariia Byelykh, M. Othus, B. Sandmaier +4 more
2022Transplantation and Cellular Therapy15 citations Open access
Semantic Scholar
Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia.
F. Appelbaum
2021Baillière's Best Practice & Research: Clinical Haematology14 citations
Semantic Scholar
A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102
R. Nakamura, W. Saber, Michael J. Martens, Alyssa Ramirez +18 more
2020Transplantation and Cellular Therapy14 citations Open access
Semantic Scholar
Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data
M. Othus, G. Garcia-Manero, J. Godwin, J. Weick +3 more
2022Haematologica13 citations Open access
Semantic Scholar
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study.
F. Milano, J. Gutman, H. Deeg, Eneida R. Nemecek +7 more
2020Blood Advances13 citations Open access
Semantic Scholar
Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies
M. Othus, M. Sekeres, S. Nand, G. Garcia-Manero +3 more
2018Leukemia13 citations Open access
Semantic Scholar
Acute Myeloid Leukemia , Version 3 . 2019
M. Tallman, Eunice S. Wang, J. Altman, F. Appelbaum +31 more
201912 citations
Semantic Scholar
2nd Cycle Remission Achievement with 7+3 and Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials
M. Othus, E. Estey, G. Garcia-Manero, B. Wood +7 more
2018Leukemia11 citations Open access
Semantic Scholar
Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
F. Appelbaum
2019Baillière's Best Practice & Research: Clinical Haematology10 citations
Semantic Scholar
A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma
V. Chow, J. Rajendran, D. Fisher, F. Appelbaum +9 more
2020American journal of hematology/oncology8 citations Open access
Semantic Scholar
High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia
Frances Linzee Mabrey, S. Chien, Timothy S. Martins, J. Annis +15 more
2018Blood8 citations
Semantic Scholar
Tipifarnib as Maintenance Therapy Did Not Improve Disease-Free Survival in Patients with Acute Myelogenous Leukemia at High Risk of Relapse: Results of the Phase III Randomized E2902 Trial
S. Luger, V. Wang, J. Rowe, M. Litzow +12 more
2021Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Tallman×21
Invite
M. Tallman — researcher profile on SciRah
M. Othus×16
Invite
M. Othus — researcher profile on SciRah
R. Larson×14
Invite
R. Larson — researcher profile on SciRah
H. Erba×13
Invite
H. Erba — researcher profile on SciRah

×12

Invite

R. Stone — researcher profile on SciRah

B. Sandmaier×11

Invite

B. Sandmaier — researcher profile on SciRah

Invite

R. Walter — researcher profile on SciRah

Invite

E. Estey — researcher profile on SciRah

Invite

S. Luger — researcher profile on SciRah

Invite

G. Marcucci — researcher profile on SciRah

B. C. Medeiros×8

Invite

B. C. Medeiros — researcher profile on SciRah

C. Bloomfield×7

Invite

C. Bloomfield — researcher profile on SciRah